AI assistant
Novonesis AS Major Shareholding Notification 2016
3377_rns_2016-10-19_b3f4a13b-72ad-48e8-ade8-e32b0d6f64b4.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Major shareholder announcement
October 19, 2016
Company announcement No. 51
In accordance with section 29 of the Danish Securities Trading Act, Novozymes hereby announces that it has been informed that Baillie Gifford & Co has increased its holding of B shares in Novozymes to 5.10%, previously reported at 4.999% in company announcement no. 36, July 2016.
Baillie Gifford & Co now holds B shares in Novozymes A/S to a total of 15,798,286 shares of a nominal value of DKK 31,596,572, equivalent to 5.10% of Novozymes A/S' share capital and 1.99% of the voting rights.
Contact information
[email protected]
Martin Riise
+45 3077 0738
[email protected]
Klaus Sindahl
+45 5363 0134
[email protected]
Nicolai Kobborg
+45 30771348
[email protected]
About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 55 00 71 27
Rethink Tomorrow
novozymes